Cytokine release syndrome in severe COVID-19.Science. 2020 05 01; 368(6490):473-474.Sci
Links
MeSH
Antibodies, Monoclonal, HumanizedBetacoronavirusC-Reactive ProteinCOVID-19Coronavirus InfectionsCytokine Release SyndromeHumansImmunotherapy, AdoptiveInterleukin-6Lymphohistiocytosis, HemophagocyticPandemicsPneumonia, ViralReceptors, Chimeric AntigenRespiratory Distress SyndromeSARS-CoV-2Severe Acute Respiratory Syndrome
Pub Type(s)
Journal Article
Research Support, N.I.H., Extramural
Language
eng
PubMed ID
32303591
Clinical Trial Links
Citation
Moore, John B., and Carl H. June. "Cytokine Release Syndrome in Severe COVID-19." Science (New York, N.Y.), vol. 368, no. 6490, 2020, pp. 473-474.
Moore JB, June CH. Cytokine release syndrome in severe COVID-19. Science. 2020;368(6490):473-474.
Moore, J. B., & June, C. H. (2020). Cytokine release syndrome in severe COVID-19. Science (New York, N.Y.), 368(6490), 473-474. https://doi.org/10.1126/science.abb8925
Moore JB, June CH. Cytokine Release Syndrome in Severe COVID-19. Science. 2020 05 1;368(6490):473-474. PubMed PMID: 32303591.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR
T1 - Cytokine release syndrome in severe COVID-19.
AU - Moore,John B,
AU - June,Carl H,
Y1 - 2020/04/17/
PY - 2020/4/19/pubmed
PY - 2020/5/6/medline
PY - 2020/4/19/entrez
SP - 473
EP - 474
JF - Science (New York, N.Y.)
JO - Science
VL - 368
IS - 6490
SN - 1095-9203
UR - https://www.unboundmedicine.com/medline/citation/32303591/Cytokine_release_syndrome_in_severe_COVID_19_
DB - PRIME
DP - Unbound Medicine
ER -